Athens, Greece

Athanassios Kotsinas

This inventor holds 1 USPTO granted patent. Top assignee: University of Dundee. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Athanassios Kotsinas: Innovator in Senescence Detection

Introduction

Athanassios Kotsinas is a notable inventor based in Athens, Greece. He has made significant contributions to the field of biomedical research, particularly in the detection of senescent cells. His innovative work has implications for understanding aging and related diseases.

Latest Patents

Kotsinas holds a patent for "Imaging compounds for detecting or imaging senescent cells." This patent describes a compound, or a salt or solvate thereof, according to a specific formula capable of detecting senescence. The compounds are useful in methods of detecting or imaging senescent cells or extracts thereof, as well as senescence in a subject or a biological sample taken from a subject. He has 1 patent to his name.

Career Highlights

Athanassios Kotsinas is affiliated with the University of Dundee, where he continues to advance his research in the field of senescence. His work is pivotal in developing new methodologies for detecting aging cells, which can lead to breakthroughs in medical science.

Collaborations

Kotsinas has collaborated with esteemed colleagues such as Vassilis G Gorgoulis and Nikolaos Lougiakis. These partnerships enhance the depth and breadth of his research, contributing to the scientific community's understanding of cellular aging.

Conclusion

Athanassios Kotsinas is a prominent figure in the field of senescence detection, with a valuable patent that showcases his innovative approach to biomedical research. His work at the University of Dundee and collaborations with other researchers highlight his commitment to advancing scientific knowledge.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…